Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 5401 AL 5415

3D Bioprinting cell-laden bioinks for engineering neural tissues and potential models for Parkinson's disease

Castilla Bolanos MA.

Prog Biomed Eng (Bristol). 2025 Dec 29;8(1). doi: 10.1088/2516-1091/ae2c2a.

A systematic review of the cerebrovascular adaptations following exposure to spaceflight or ground-based analogs: lessons from human and animal studies

Daniel Estrella L, Sveeggen TM, de la Guardia G, Cacho J, Stauch KL, Bagher P.

NPJ Microgravity. 2025 Dec 12;12(1):1. doi: 10.1038/s41526-025-00540-6.

Olfactory Dysfunction and/or RBD for Mapping Parkinson's Disease Subtypes?

Velucci V, Defazio G.

Eur J Neurol. 2025 Dec;32(12):e70468. doi: 10.1111/ene.70468.

Mirtazapine for gastrointestinal side effects of glucagon-like peptide-1 receptor agonist therapy in older adults

Khan AR, Makhoul GW, Raji MA.

Endocr Regul. 2025 Dec 12;59(1):260-264. doi: 10.2478/enr-2025-0030. Print 2025 Jan 1.

Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024

Isaković J, Athanassiadis A, Khubeis M.

J Mol Med (Berl). 2025 Dec 13;104(1):2. doi: 10.1007/s00109-025-02613-1.

The glymphatic system in neurodegenerative diseases and brain tumors: mechanistic insights, biomarker advances, and therapeutic opportunities

Jia L, Chen Y, Li H, Zhao K, Ge S, Wang C, Zhao J, Li F, Zhang L, Yao A.

Acta Neuropathol Commun. 2025 Dec 13;14(1):19. doi: 10.1186/s40478-025-02203-9.

Development and emerging trends in gastrointestinal dysfunction of Parkinson's disease: a decade-long bibliometric analysis

Sun Y, Yang H, Zhang J, Cong S, Wang L, Yu T.

Front Aging Neurosci. 2025 Nov 28;17:1712302. doi: 10.3389/fnagi.2025.1712302. eCollection 2025.

Validation of an aspiration risk prediction model for Parkinson's disease based on nomogram: a single-center study

Xu YY, Wei Y, Sha L.

PeerJ. 2025 Dec 8;13:e20443. doi: 10.7717/peerj.20443. eCollection 2025.

Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy

Guo XY, Song DY, Wu MY, Zhang JQ, Li JY, Yuan L.

MedComm (2020). 2025 Dec 12;6(12):e70540. doi: 10.1002/mco2.70540. eCollection 2025 Dec.

Dementia with Grains: A Clinical Mimic of Dementia with Lewy Bodies - Case Report

Gardiner SL, Fransen NL, Rozemuller AJM, Lemstra EW.

Case Rep Neurol. 2025 Nov 17;17(1):191-197. doi: 10.1159/000549534. eCollection 2025 Jan-Dec.

Editorial: Advancing personalized diagnosis and treatment in Parkinson's disease: integrating biomarkers, neuroimaging, and artificial intelligence

Giani AM, Shafeek S, Tatti E.

Front Neurosci. 2025 Nov 27;19:1734524. doi: 10.3389/fnins.2025.1734524. eCollection 2025.

Pill retention in Parkinson's disease presenting as a soft tissue mass

Wilson MJ, Hafeez B, Tinson AJ.

BMJ Case Rep. 2025 Dec 15;18(12):e267473. doi: 10.1136/bcr-2025-267473.

Neurotoxicity and Potential Mechanisms of Exposure to Per- and Polyfluoroalkyl Substances (PFASs)

Song Y, Ma Y, Huang Y, Song D, Hu C, Zhang X, Chen Y, Zhang L, Lu L.

Mol Neurobiol. 2025 Dec 16;63(1):297. doi: 10.1007/s12035-025-05573-2.

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis

Li J, Zhou R, Deng J, Zhou H, Hu J, Wang X.

BMC Neurol. 2025 Dec 15;25(1):504. doi: 10.1186/s12883-025-04526-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias